To further research the mechanism between FGF9 and the development of DN, we examined the expression levels of FGF9 and FGFRs in a diabetes mouse model (DM group) induced by STZ injection (Figure 2A). The gene discussed is FGF9; the disease is liver dysplastic nodule.